Merck & Co. Pounces On Moderna mRNA-Based Cancer Vaccine Option

 
• By Jessica Merrill
  
tiger pouncing
Merck exercised an option for Moderna's cancer vaccine • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business